Tema Heart & Health ETF (NASDAQ:HRTS) Trading Up 1% – What’s Next?

Tema Heart & Health ETF (NASDAQ:HRTS)’s stock price was up 1% during mid-day trading on Monday . The company traded as high as $36.63 and last traded at $36.55. 12,327 shares were traded during mid-day trading, an increase of 92% from the average daily volume of 6,421 shares. The stock had previously closed at $36.19.

Tema Heart & Health ETF Stock Up 1.0%

The company has a market capitalization of $54.46 million, a P/E ratio of 22.06 and a beta of 0.68. The firm has a fifty day simple moving average of $34.07 and a 200-day simple moving average of $34.69.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. CoreCap Advisors LLC boosted its holdings in shares of Tema Heart & Health ETF by 17.2% in the fourth quarter. CoreCap Advisors LLC now owns 60,679 shares of the company’s stock valued at $2,141,000 after buying an additional 8,903 shares during the period. Jane Street Group LLC lifted its position in Tema Heart & Health ETF by 9.4% in the 2nd quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after acquiring an additional 3,202 shares in the last quarter. Stifel Financial Corp lifted its position in Tema Heart & Health ETF by 19.8% in the 4th quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock valued at $1,187,000 after acquiring an additional 5,571 shares in the last quarter. Royal Bank of Canada lifted its position in Tema Heart & Health ETF by 8.8% in the 1st quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock valued at $710,000 after acquiring an additional 1,703 shares in the last quarter. Finally, Brookstone Capital Management acquired a new position in Tema Heart & Health ETF in the 4th quarter worth $364,000.

Tema Heart & Health ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.